360 related articles for article (PubMed ID: 28219702)
1. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis.
Sajnani K; Islam F; Smith RA; Gopalan V; Lam AK
Biochimie; 2017 Apr; 135():164-172. PubMed ID: 28219702
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunctions in cancer: genetic defects and oncogenic signaling impinging on TCA cycle activity.
Desideri E; Vegliante R; Ciriolo MR
Cancer Lett; 2015 Jan; 356(2 Pt A):217-23. PubMed ID: 24614286
[TBL] [Abstract][Full Text] [Related]
3. Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process.
Salminen A; Kauppinen A; Hiltunen M; Kaarniranta K
Ageing Res Rev; 2014 Jul; 16():45-65. PubMed ID: 24910305
[TBL] [Abstract][Full Text] [Related]
4. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
Menendez JA; Alarcón T; Joven J
Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
[TBL] [Abstract][Full Text] [Related]
5. Inborn and acquired metabolic defects in cancer.
Frezza C; Pollard PJ; Gottlieb E
J Mol Med (Berl); 2011 Mar; 89(3):213-20. PubMed ID: 21301796
[TBL] [Abstract][Full Text] [Related]
6. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Laurenti G; Tennant DA
Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.
Porporato PE; Payen VL; Baselet B; Sonveaux P
Cell Mol Life Sci; 2016 Apr; 73(7):1349-63. PubMed ID: 26646069
[TBL] [Abstract][Full Text] [Related]
8. Global transcription analysis of Krebs tricarboxylic acid cycle mutants reveals an alternating pattern of gene expression and effects on hypoxic and oxidative genes.
McCammon MT; Epstein CB; Przybyla-Zawislak B; McAlister-Henn L; Butow RA
Mol Biol Cell; 2003 Mar; 14(3):958-72. PubMed ID: 12631716
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria in cancer: at the crossroads of life and death.
Fogg VC; Lanning NJ; Mackeigan JP
Chin J Cancer; 2011 Aug; 30(8):526-39. PubMed ID: 21801601
[TBL] [Abstract][Full Text] [Related]
10. The impact of mitochondria on cancer treatment resistance.
van der Merwe M; van Niekerk G; Fourie C; du Plessis M; Engelbrecht AM
Cell Oncol (Dordr); 2021 Oct; 44(5):983-995. PubMed ID: 34244972
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
[TBL] [Abstract][Full Text] [Related]
12. Impaired mitochondrial energy metabolism in Alzheimer's disease: Impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape.
Salminen A; Haapasalo A; Kauppinen A; Kaarniranta K; Soininen H; Hiltunen M
Prog Neurobiol; 2015 Aug; 131():1-20. PubMed ID: 26001589
[TBL] [Abstract][Full Text] [Related]
13. Role of mitochondrial dysfunction in cancer progression.
Hsu CC; Tseng LM; Lee HC
Exp Biol Med (Maywood); 2016 Jun; 241(12):1281-95. PubMed ID: 27022139
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.
Chen JQ; Russo J
Biochim Biophys Acta; 2012 Dec; 1826(2):370-84. PubMed ID: 22750268
[TBL] [Abstract][Full Text] [Related]
15. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
[TBL] [Abstract][Full Text] [Related]
16. Oncometabolites: tailoring our genes.
Nowicki S; Gottlieb E
FEBS J; 2015 Aug; 282(15):2796-805. PubMed ID: 25864878
[TBL] [Abstract][Full Text] [Related]
17. The functional roles of TCA cycle metabolites in cancer.
Eniafe J; Jiang S
Oncogene; 2021 May; 40(19):3351-3363. PubMed ID: 33864000
[TBL] [Abstract][Full Text] [Related]
18. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).
El Sayed SM; Mahmoud AA; El Sawy SA; Abdelaal EA; Fouad AM; Yousif RS; Hashim MS; Hemdan SB; Kadry ZM; Abdelmoaty MA; Gabr AG; Omran FM; Nabo MM; Ahmed NS
Med Hypotheses; 2013 Nov; 81(5):866-70. PubMed ID: 24071366
[TBL] [Abstract][Full Text] [Related]
19. Krebs cycle dysfunction shapes epigenetic landscape of chromatin: novel insights into mitochondrial regulation of aging process.
Salminen A; Kaarniranta K; Hiltunen M; Kauppinen A
Cell Signal; 2014 Jul; 26(7):1598-603. PubMed ID: 24704120
[TBL] [Abstract][Full Text] [Related]
20. Cells silenced for SDHB expression display characteristic features of the tumor phenotype.
Cervera AM; Apostolova N; Crespo FL; Mata M; McCreath KJ
Cancer Res; 2008 Jun; 68(11):4058-67. PubMed ID: 18519664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
